Recombinant liposomal factor VIIa - Recoly

Drug Profile

Recombinant liposomal factor VIIa - Recoly

Alternative Names: LongSeven; NecLip-rFVIIa

Latest Information Update: 14 Sep 2015

Price : $50

At a glance

  • Originator Recoly
  • Class Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
  • Mechanism of Action Factor VIIa stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Haemophilia A

Most Recent Events

  • 14 Sep 2015 Discontinued - Phase-I/II for Haemophilia A in Russia (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top